SMi Source Lesson HCV: Therapies and Prophylaxis

  • SMi Source lesson HCV: Therapies and Prophylaxis has the following microlearning topics

    • 1. Goals of Therapy -Changed

    2. Therapies for HCV

    3. Review of Major Trials

    4. Genotypes and HCV Therapies

    5. Factors affecting Therapy Decisions

    6. Therapies Under Development

    7. HCV Vaccines

  • Lesson HCV: Therapies and Prophylaxis teaches these concepts

    • Goals of Therapy, End-of Treatment Responders with Relapse (RR)

    Goals of Therapy, Sustained Response (Sustained Virologic Response; SVR)

  • Lesson HCV: Therapies and Prophylaxis addresses these key points

    • Patients with RR:

    • Viral loads below detection
    • Virus not in circulation

    The main goal of hepatitis C therapy is to completely eradicate the hepatitis C virus.

  • Lesson HCV: Therapies and Prophylaxis introduces and defines these terms

    • End-of-treatment responders with relapse (RR): A patient whose HCV RNA was not detectable at the end of therapy but has reappeared 6 months after therapy.

    Eradication: Persistent undetectable HCV RNA in the plasma 6 months after treatment.

    Sustained virologic responder: A patient with no detectable HCV RNA 6 months after treatment.

    Non-responder: Patients with HCV RNA still detected at the end of therapy.

    End-of treatment responders with relapse (RR): A patient whose HCV RNA was not detectable at the end of therapy but has reappeared 6 months after therapy.